-transparent.png){kind=logo}
Inflammation is a defensive reaction for external stimuli to the human body and generally accompanied by immune responses, which is associated with multiple diseases such as atherosclerosis, type 2 diabetes, Alzheimer's disease, psoriasis, asthma, chronic lung diseases, inflammatory bowel disease, and multiple virus-associated diseases. Epigenetic mechanisms have been demonstrated to play a key role in the regulation of inflammation. Common epigenetic regulations are DNA methylation, histone modifications, and non-coding RNA expression; among these, histone modifications embrace various post-modifications including acetylation, methylation, phosphorylation, ubiquitination, and ADP ribosylation. This review focuses on the significant role of histone modifications in the progression of inflammatory diseases, providing the potential target for clinical therapy of inflammation-associated diseases.
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
January 2013,
Current pharmaceutical design,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
August 2019,
Biochimica et biophysica acta. Molecular basis of disease,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
January 2013,
Current pharmaceutical design,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
February 2021,
The Biochemical journal,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
March 2024,
Epigenomics,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
February 2023,
Seminars in cell & developmental biology,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
January 2022,
Frontiers in oncology,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
January 2015,
ACS chemical biology,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
April 2017,
Cryobiology,
Yingying Lin, and
Ting Qiu, and
Guifeng Wei, and
Yueyue Que, and
Wenxin Wang, and
Yichao Kong, and
Tian Xie, and
Xiabin Chen
April 2024,
Biology of reproduction,
